TKL Research, Inc. Selects Medidata Solutions, Inc.’ Clinical Trial Management System to Drive Future Growth

NEW YORK--(BUSINESS WIRE)--TKL Research, a clinical research organization (CRO), has selected Medidata CTMS™, a leading software-as-a-service (SaaS) clinical trial management system offered by Medidata Solutions (NASDAQ: MDSO), as part of an initiative to expand its clinical trial operations. As TKL’s operations accelerate, delivering on its reputation for rapid study startup times and first-rate patient enrollment practices will become increasingly complex. Medidata CTMS allows TKL to identify sites that can rapidly enroll the right patients by measuring actual recruitment milestones against site-forecasted times. To meet the growing needs of TKL’s multisystem, multi-trial operations, the study metrics captured by Medidata CTMS are being used to evaluate resource deployment and streamline processes—from site selection to site payment.

Back to news